{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:44:58Z","timestamp":1793256298971,"version":"4.5.0"},"reference-count":204,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>The emergence of antibiotic-resistant pathogenic bacteria in recent decades leads us to an urgent need for the development of new antibacterial agents. The species of the genus Amycolatopsis are known as producers of secondary metabolites that are used in medicine and agriculture. The complete genome sequences of the Amycolatopsis demonstrate a wide variety of biosynthetic gene clusters, which highlights the potential ability of actinomycetes of this genus to produce new antibiotics. In this review, we summarize information about antibiotics produced by Amycolatopsis species. This knowledge demonstrates the prospects for further study of this genus as an enormous source of antibiotics.<\/jats:p>","DOI":"10.3390\/antibiotics10101254","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T23:13:32Z","timestamp":1634512412000},"page":"1254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Looking Back to Amycolatopsis: History of the Antibiotic Discovery and Future Prospects"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4799-1318","authenticated-orcid":false,"given":"Olga V.","family":"Kisil","sequence":"first","affiliation":[{"name":"Gause Institute of New Antibiotics, 119021 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9632-6854","authenticated-orcid":false,"given":"Tatiana A.","family":"Efimenko","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 119021 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3131-1031","authenticated-orcid":false,"given":"Olga V.","family":"Efremenkova","sequence":"additional","affiliation":[{"name":"Gause Institute of New Antibiotics, 119021 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/MMBR.00005-07","article-title":"Genomics of Actinobacteria: Tracing the evolutionary history of an ancient phylum","volume":"71","author":"Ventura","year":"2007","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Song, Z., Xu, T., Wang, J., Hou, Y., Liu, C., Liu, S., and Wu, S. (2021). Secondary Metabolites of the Genus Amycolatopsis: Structures, Bioactivities and Biosynthesis. Molecules, 26.","DOI":"10.3390\/molecules26071884"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cbic.201500542","article-title":"Progress in understanding the genetic information and biosynthetic pathways behind Amycolatopsis antibiotics, with implications for the continued discovery of novel drugs","volume":"17","author":"Chen","year":"2016","journal-title":"ChemBioChem"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12088-016-0590-8","article-title":"Genetics and genomics of the genus Amycolatopsis","volume":"56","author":"Kumari","year":"2016","journal-title":"Indian J. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s11274-014-1622-3","article-title":"Current biotechnological applications of the genus Amycolatopsis","volume":"30","author":"Amoroso","year":"2014","journal-title":"World J. Microbiol. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1099\/ijsem.0.002682","article-title":"Amycolatopsis oliviviridis sp. nov., a novel polylactic acid-bioplastic-degrading actinomycete isolated from paddy soil","volume":"68","author":"Penkhrue","year":"2018","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1099\/00207713-36-1-29","article-title":"Two new genera of nocardioform actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov","volume":"36","author":"Lechevalier","year":"1986","journal-title":"Int. J. Syst. Bacteriol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1099\/ijs.0.012427-0","article-title":"Amycolatopsis halophila sp. nov., a halophilic actinomycete isolated from a salt lake","volume":"60","author":"Tang","year":"2010","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1099\/ijs.0.64903-0","article-title":"Amycolatopsis saalfeldensis sp. nov., a novel actinomycete isolated from a medieval alum slate mine","volume":"57","author":"Carlsohn","year":"2007","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fmicb.2018.00369","article-title":"Comparative genomics and biosynthetic potential analysis of two lichen-isolated Amycolatopsis strains","volume":"9","author":"Genilloud","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1099\/ijs.0.000026-0","article-title":"Amycolatopsis marina sp. nov., an actinomycete isolated from an ocean sediment","volume":"59","author":"Bian","year":"2009","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1099\/00207713-51-1-187","article-title":"Amycolatopsis sacchari sp. nov., a moderately thermophilic actinomycete isolated from vegetable matter","volume":"51","author":"Goodfellow","year":"2001","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1039\/C7OB00614D","article-title":"Rifamorpholines A\u2013E, potential antibiotics from locust-associated actinobacteria Amycolatopsis sp. Hca4","volume":"15","author":"Xiao","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/acs.orglett.6b03831","article-title":"Macrotermycins A-D, glycosylated macrolactams from a termite-associated Amycolatopsis sp. M39","volume":"19","author":"Beemelmanns","year":"2017","journal-title":"Org. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1099\/ijs.0.02685-0","article-title":"Amycolatopsis palatopharyngis sp. nov., a potentially pathogenic actinomycete isolated from a human clinical source","volume":"54","author":"Huang","year":"2004","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_16","unstructured":"Whitman, W.B. (2015). Amycolatopsis. Bergey\u2019s Manual of Systematic Bacteriology, John Wiley & Sons."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1099\/ijs.0.02691-0","article-title":"Amycolatopsis kentuckyensis sp. nov., Amycolatopsis lexingtonensis sp. nov. and Amycolatopsis pretoriensis sp. nov., isolated from equine placentas","volume":"53","author":"Labeda","year":"2003","journal-title":"Int. J. Syst. Evol. Microbiol"},{"key":"ref_18","unstructured":"(2021, June 22). LPSN\u2014List of Prokaryotic Names with Standing in Nomenclature. Available online: http:\/\/www.bacterio.net\/amycolatopsis.html."},{"key":"ref_19","unstructured":"(2021, June 22). The National Center for Biotechnology Information (Assembly), Available online: www.ncbi.nlm.nih.gov\/assembly."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Adamek, M., Alanjary, M., Sales-Ortells, H., Goodfellow, M., Bull, A.T., Winkler, A., Wibberg, D., Kalinowski, J., and Ziemert, N. (2018). Comparative genomics reveals phylogenetic distribution patterns of secondary metabolites in Amycolatopsis species. BMC Genomics, 19.","DOI":"10.1186\/s12864-018-4809-4"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3389\/fmicb.2018.02281","article-title":"Revisiting the taxonomic status of the biomedically and industrially important genus Amycolatopsis, using a phylogenomic approach","volume":"9","author":"Sangal","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.syapm.2006.01.007","article-title":"Exploration of Amycolatopsis diversity in soil using genus-specific primers and novel selective media","volume":"29","author":"Tan","year":"2006","journal-title":"Syst. Appl. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Doroghazi, J.R., and Metcalf, W.W. (2013). Comparative genomics of actinomycetes with a focus on natural product biosynthetic genes. BMC Genomics, 14.","DOI":"10.1186\/1471-2164-14-611"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ja.2014.79","article-title":"Amycolatopsis roodepoortensis sp. nov. and Amycolatopsis speibonae sp. nov.: Antibiotic-producing actinobacteria isolated from South African soils","volume":"67","author":"Everest","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_25","unstructured":"(2021, June 22). Minimum Information about a Biosynthetic Gene cluster. Available online: http:\/\/mibig.secondarymetabolites.org."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nchembio.1890","article-title":"Minimum information about a biosynthetic gene cluster","volume":"11","author":"Medema","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2672.2011.05058.x","article-title":"Evaluation of the antibiotic biosynthetic potential of the genus Amycolatopsis and description of Amycolatopsis circi sp. nov., Amycolatopsis equina sp. nov. and Amycolatopsis hippodromi sp. nov","volume":"111","author":"Everest","year":"2011","journal-title":"J. Appl. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ja.2006.74","article-title":"Genomic analyses lead to novel secondary metabolites. Part 3. ECO-0501, a novel antibacterial of a new class","volume":"59","author":"Banskota","year":"2006","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41589-018-0193-2","article-title":"A genetics-free method for high-throughput discovery of cryptic microbial metabolites","volume":"15","author":"Xu","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acssynbio.8b00361","article-title":"Atolypenes, Tricyclic Bacterial Sesterterpenes Discovered Using a Multiplexed In Vitro Cas9-TAR Gene Cluster Refactoring Approach","volume":"8","author":"Kim","year":"2019","journal-title":"ACS Synth Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ja.2008.95","article-title":"Mutactimycin E, a new anthracycline antibiotic with Gram-positive activity","volume":"61","author":"Hopp","year":"2008","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3390\/md12042326","article-title":"A new benzofuran glycoside and indole alkaloids from a sponge-associated rare actinomycete, Amycolatopsis sp.","volume":"12","author":"Kwon","year":"2014","journal-title":"Mar. Drugs."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/14786419.2018.1434639","article-title":"Pradimicin-IRD from Amycolatopsis sp. IRD-009 and its antimicrobial and cytotoxic activities","volume":"33","author":"Bauermeister","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41429-018-0028-0","article-title":"Dipyrimicin A and B, microbial compounds isolated from Amycolatopsis sp. K16-0194","volume":"71","author":"Izuta","year":"2018","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.7164\/antibiotics.37.1260","article-title":"Isolation and structural determination of siderochelin C, a fermentation product of an unusual Actinomycetes sp.","volume":"37","author":"Mitscher","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_36","first-page":"69","article-title":"Siderochelins with anti-mycobacterial activity from Amycolatopsis sp. LZ149","volume":"13","author":"Lu","year":"2015","journal-title":"Chin. J. Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7164\/antibiotics.47.668","article-title":"Novel antibiotics, amythiamicins. I. Taxonomy, fermentation, isolation, physico-chemical properties, and antimicrobial activity","volume":"47","author":"Shimanaka","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.7164\/antibiotics.47.1153","article-title":"Novel antibiotics, amythiamicins. III. Structure elucidations of amythiamicins A, B and C","volume":"47","author":"Shimanaka","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e01091-14","DOI":"10.1128\/genomeA.01091-14","article-title":"Draft genome sequence of ristocetin-producing strain Amycolatopsis sp. strain MJM2582 isolated in South Korea","volume":"2","author":"Kwun","year":"2014","journal-title":"Genome Announc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1128\/AAC.03349-14","article-title":"Antibiotic resistance mechanisms inform discovery: Identification and characterization of a novel amycolatopsis strain producing ristocetin","volume":"58","author":"Truman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","unstructured":"Grundy, W.E., Sinclair, A.C., Theriault, R.J., Goldstein, A.W., Rickher, C.J., Warren, H.B., Oliver, T.J., and Sylvester, J.C. (1956). Ristocetin, microbiologic properties. Antibiot. Annu., 687\u2013692."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ja.2008.54","article-title":"Pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.","volume":"61","author":"Igarashi","year":"2008","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ja.2017.135","article-title":"Valgamicin C, a novel cyclic depsipeptide containing the unusual amino acid cleonine, and related valgamicins A, T and V produced by Amycolatopsis sp. ML1-hF4","volume":"71","author":"Hashizume","year":"2017","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.fitote.2019.04.011","article-title":"A new phthalazinone derivative and a new isoflavonoid glycoside from lichen-associated Amycolatopsis sp.","volume":"135","author":"Zheng","year":"2019","journal-title":"Fitoterapia"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s00284-020-02049-5","article-title":"Diverse secondary metabolites from a lichen-derived Amycolatopsis strain","volume":"77","author":"Liu","year":"2020","journal-title":"Curr. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.1807613115","article-title":"Amycomicin is a potent and specific antibiotic discovered with a targeted interaction screen","volume":"115","author":"Pishchany","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.micres.2011.12.003","article-title":"Novel pyridinium compound from marine actinomycete, Amycolatopsis alba var. nov. DVR D4 showing antimicrobial and cytotoxic activities in vitro","volume":"167","author":"Dasari","year":"2012","journal-title":"Microbiol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.7164\/antibiotics.56.1004","article-title":"Kigamicins, novel antitumor antibiotics. I. Taxonomy, isolation, physico-chemical properties and biological activities","volume":"56","author":"Kunimoto","year":"2003","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_49","first-page":"1","article-title":"Carbamothioic S-acid derivative and kigamicins, the activated production of silent metabolites in Amycolatopsis alba DSM 44262\u0394abm9 elicited by N-acetyl-D-glucosamine","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Prod. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1021\/acs.orglett.9b01891","article-title":"Identification of the Bacterial Maytansinoid Gene Cluster asc Provides Insights into the Post-PKS Modifications of Ansacarbamitocin Biosynthesis","volume":"21","author":"Li","year":"2019","journal-title":"Org. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"985","DOI":"10.7164\/antibiotics.32.985","article-title":"Studies on bacterial cell wall inhibitors. VII. Azureomycins A and B, new antibiotics produced by Pseudonocardia azurea nov. sp. Taxonomy of the producing organism, isolation, characterization and biological properties","volume":"32","author":"Omura","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.gdata.2013.12.003","article-title":"Genome sequencing and annotation of Amycolatopsis azurea DSM 43854(T)","volume":"12","author":"Khatri","year":"2014","journal-title":"Genom. Data."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.7164\/antibiotics.41.1525","article-title":"Novel antifungal antibiotics octacosamicins A and B. I. Taxonomy, fermentation and isolation, physico-chemical properties and biological activities","volume":"41","author":"Dobashi","year":"1988","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.7164\/antibiotics.41.1533","article-title":"Novel antifungal antibiotics octacosamicins A and B. II. The structure elucidation using various NMR spectroscopic methods","volume":"41","author":"Dobashi","year":"1988","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.7164\/antibiotics.47.334","article-title":"Balhimycin, a new glycopeptide antibiotic produced by Amycolatopsis sp. Y-86,21022. Taxonomy, production, isolation and biological activity","volume":"47","author":"Nadkarni","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_56","first-page":"242","article-title":"LL-AV290, a new antibiotic. I. Fermentation, isolation, and characterization","volume":"8","author":"Kunstmann","year":"1968","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.7164\/antibiotics.36.1683","article-title":"Epimerization and stereochemistry of avoparcin","volume":"36","author":"Ellestad","year":"1983","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1469-0691.2000.00128.x","article-title":"Avoparcin and virginiamycin as animal growth promoters: A plea for science in decision-making","volume":"6","author":"Acar","year":"2000","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF01961864","article-title":"In vitro activity of the new glycopeptide decaplanin","volume":"11","author":"Neu","year":"1992","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1099\/ijs.0.02586-0","article-title":"Amycolatopsis decaplanina sp. nov., a novel member of the genus with unusual morphology","volume":"54","author":"Wink","year":"2004","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1021\/acs.jnatprod.0c00547","article-title":"Amycolasporins and dibenzoyls from lichen-associated Amycolatopsis hippodrome and their antibacterial and anti-inflammatory activities","volume":"83","author":"Jin","year":"2020","journal-title":"J. Nat. Prod."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6185","DOI":"10.1128\/AAC.03512-14","article-title":"Overproduction of Ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum MG417-CF17","volume":"58","author":"Spohn","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41589-019-0400-9","article-title":"A computational framework to explore large-scale biosynthetic diversity","volume":"16","author":"Mullowney","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_64","first-page":"44","article-title":"New antibiotics, actinoidin","volume":"2","author":"Shorin","year":"1957","journal-title":"Antibiotiki"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1078\/072320203322337290","article-title":"Three new antibiotics producing species of the genus Amycolatopsis, Amycolatopsis balhimycina sp. nov., A. tolypomycina sp. nov., A. vancoresmycina sp. nov., and description of Amycolatopsis keratiniphila subsp. keratiniphila subsp. nov. and A. keratiniphila subsp. nogabecina subsp. nov","volume":"26","author":"Wink","year":"2003","journal-title":"Syst. Appl. Microbiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/AAC.2.4.287","article-title":"Cephamycins, a new family of beta-lactam antibiotics. IV. In vivo studies","volume":"2","author":"Miller","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/AAC.2.3.122","article-title":"Cephamycins, a new family of beta-lactam antibiotics. I. Production by actinomycetes, including Streptomyces lactamdurans sp. n","volume":"2","author":"Stapley","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0723-2020(00)80041-7","article-title":"Characterization of the ribosomal rrnD operon of the cephamycin-producer \u2019Nocardia lactamdurans\u2019 shows that this actinomycete belongs to the genus Amycolatopsis","volume":"23","author":"Barreiro","year":"2000","journal-title":"Syst. Appl. Microbiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0076-6879(09)04816-2","article-title":"Enzymology of beta-lactam compounds with cephem structure produced by actinomycete","volume":"458","author":"Liras","year":"2009","journal-title":"Methods Enzymol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7164\/antibiotics.29.670","article-title":"Efrotomycin, a new antibiotic from Streptomyces lactamdurans","volume":"29","author":"Wax","year":"1976","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.7164\/antibiotics.39.1509","article-title":"Benzanthrins A and B, a new class of quinone antibiotics. I. Discovery, fermentation and antibacterial activity","volume":"39","author":"Theriault","year":"1986","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.7164\/antibiotics.39.1515","article-title":"Benzanthrins A and B, a new class of quinone antibiotics. II. Isolation, elucidation of structure and potential antitumor activity","volume":"39","author":"Rasmussen","year":"1986","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_73","unstructured":"Philip, J.E., Schenck, J.R., and Hargie, M.P. (1957). Ristocetins A and B, two new antibiotics; isolation and properties. Antibiot. Annu., 699\u2013705."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7164\/antibiotics.38.713","article-title":"Structural characterization of glycopeptide antibiotics related to vancomycin by fast atom bombardment mass spectrometry","volume":"38","author":"Roberts","year":"1985","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00253-017-8648-z","article-title":"Amexanthomycins A-J, pentangular polyphenols produced by Amycolatopsis mediterranei S699\u2206rifA","volume":"102","author":"Li","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.7164\/antibiotics.45.1819","article-title":"Dethymicin, a novel immunosuppressant isolated from an Amycolatopsis. Fermentation, isolation, physico-chemical properties and biological activities","volume":"45","author":"Ueno","year":"1992","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7164\/antibiotics.41.264","article-title":"Isolation and structure of a new ansamycin antibiotic kanglemycin A from a Nocardia","volume":"41","author":"Wang","year":"1988","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molcel.2018.08.028","article-title":"Mode of action of Kanglemycin A, an ansamycin natural product that is active against rifampicin-resistant Mycobacterium tuberculosis","volume":"72","author":"Mosaei","year":"2018","journal-title":"Mol. Cell."},{"key":"ref_79","first-page":"146","article-title":"Rifomycin, a new antibiotic; preliminary report","volume":"14","author":"Sensi","year":"1959","journal-title":"Farmaco Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7164\/antibiotics.25.356","article-title":"An Australian isolate of Nocardia mediterranea producing rifamycin SV","volume":"25","author":"Birner","year":"1972","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7164\/antibiotics.47.613","article-title":"31-Homorifamycin W, a novel metabolite from Amycolatopsis mediterranei","volume":"47","author":"Wang","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1128\/JB.01295-12","article-title":"Complete genome sequence of Amycolatopsis mediterranei S699 based on de novo assembly via a combinatorial sequencing strategy","volume":"194","author":"Tang","year":"2012","journal-title":"J. Bacteriol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1021\/acs.orglett.8b03792","article-title":"Isolation of 11,12-seco-Rifamycin W derivatives reveals a cleavage pattern of the rifamycin ansa chain","volume":"21","author":"Shi","year":"2019","journal-title":"Org. Lett."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7164\/antibiotics.42.640","article-title":"Oxidation processes in the biosynthesis of the tetracenomycin and elloramycin antibiotics","volume":"42","author":"Anderson","year":"1989","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Qiao, X., Gan, M., Wang, C., Liu, B., Shang, Y., Li, Y., and Chen, S. (2019). Tetracenomycin X exerts antitumour activity in lung cancer cells through the downregulation of cyclin D1. Mar. Drug., 17.","DOI":"10.3390\/md17010063"},{"key":"ref_86","first-page":"642","article-title":"Streptomyces orientalis, n. sp., the source of vancomycin","volume":"6","author":"Brigham","year":"1956","journal-title":"Antibiot. Chemother. (Northfield)"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7164\/antibiotics.37.446","article-title":"N-demethylvancomycin, a novel antibiotic produced by a strain of Nocardia orientalis. Taxonomy and fermentation","volume":"37","author":"Boeck","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7164\/antibiotics.37.917","article-title":"A51568A: N-demethylvancomycin","volume":"37","author":"Hunt","year":"1984","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"750","DOI":"10.7164\/antibiotics.51.750","article-title":"Antibiotic activities and affinities for bacterial cell wall analogue of N-demethylvancomycin and its derivatives","volume":"51","author":"Yan","year":"1998","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_90","unstructured":"Lapchinskaia, O.A., Katrukha, G.S., Pogozheva, V.V., Ponomarenko, V.I., Filicheva, V.A., Kharitonova, L.A., Lapchinskaia, M.Y., Yakovenko, A.N., Nifantiev, N.E., and Shashkov, A.S. (2017). Amycolatopsis orientalis Strain\u2014Producer of the Antibiotic Dimethylvancomycin and Method of the Antibiotic Preparation. (2633511), Patent RU, (In Russian)."},{"key":"ref_91","first-page":"1631","article-title":"Structural analysis of antibiotic INA 9301 from Amycolatopsis orientalis","volume":"3","author":"Shashkov","year":"2008","journal-title":"NPC"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ja.2016.115","article-title":"Three structurally-related impurities in norvancomycin drug substance","volume":"70","author":"Jiang","year":"2017","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jbiotec.2017.02.013","article-title":"Complete genome sequence of Amycolatopsis orientalis CPCC200066, the producer of norvancomycin","volume":"10","author":"Lei","year":"2017","journal-title":"J. Biotechnol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.7164\/antibiotics.45.180","article-title":"Quartromicin, a complex of novel antiviral antibiotics. I. Production, isolation, physico-chemical properties and antiviral activity","volume":"45","author":"Tsunakawa","year":"1992","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.7164\/antibiotics.42.1453","article-title":"UK-69,753, a novel member of the efrotomycin family of antibiotics. I. Taxonomy of the producing organism, fermentation and isolation","volume":"42","author":"Pacey","year":"1989","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.7164\/antibiotics.42.1610","article-title":"UK-69,753, a novel member of the efrotomycin family of antibiotics. II. Structure determination and biological activity","volume":"42","author":"Jefson","year":"1989","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"931","DOI":"10.7164\/antibiotics.43.931","article-title":"MM 47761 and MM 49721, glycopeptide antibiotics produced by a new strain of Amycolatopsis orientalis. Isolation, purification and structure determination","volume":"43","author":"Box","year":"1990","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"807","DOI":"10.7164\/antibiotics.44.807","article-title":"MM 55266 and MM 55268, glycopeptide antibiotics produced by a new strain of Amycolatopsis. Isolation, purification and structure determination","volume":"44","author":"Box","year":"1991","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1134\/S1068162009040128","article-title":"The structure of antibiotic eremomycin B","volume":"35","author":"Berdnikova","year":"2009","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.7164\/antibiotics.42.1790","article-title":"Eremomycin\u2014New glycopeptide antibiotics. Chemical properties and structure","volume":"42","author":"Gause","year":"1989","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_101","first-page":"571","article-title":"Eremomycin\u2014A new antibiotic from the cyclic glycopeptide group","volume":"32","author":"Gauze","year":"1987","journal-title":"Antibiot. Med. Biotekhnol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7164\/antibiotics.41.819","article-title":"New glycopeptide antibiotics. I. The structures of orienticins","volume":"41","author":"Tsuji","year":"1988","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.7164\/antibiotics.41.1506","article-title":"New glycopeptide antibiotics: II. The isolation and structures of chloroorienticins","volume":"41","author":"Tsuji","year":"1988","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.34.11.2137","article-title":"In vitro activity of LY264826, a new glycopeptide antibiotic, against Gram-positive bacteria isolated from patients with cancer","volume":"34","author":"Rolston","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.7164\/antibiotics.56.1012","article-title":"Kigamicins, novel antitumor antibiotics. II. Structure determination","volume":"56","author":"Kunimoto","year":"2003","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ja.2006.29","article-title":"Antitumor effect of kigamicin D on mouse tumor models","volume":"59","author":"Masuda","year":"2006","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1099\/ijs.0.64974-0","article-title":"Amycolatopsis regifaucium sp. nov., a novel actinomycete that produces kigamicins","volume":"57","author":"Tan","year":"2007","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_108","unstructured":"Biryukov, M.V., Zakalyukina, S.E., and Osterman, I.A. (2020). Strain of Amycolatopsis rifamycinica\u2014Producer of the Antibiotic Tetracenomycin X. (2724537), Patent RU, (In Russian)."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s41589-020-0578-x","article-title":"Tetracenomycin X inhibits translation by binding within the ribosomal exit tunnel","volume":"16","author":"Osterman","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.1021\/jacs.8b03896","article-title":"Bioinformatic expansion and discovery of thiopeptide antibiotics","volume":"140","author":"Schwalen","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12223-018-0642-z","article-title":"Echinosporin antibiotics isolated from Amycolatopsis strain and their antifungal activity against root-rot pathogens of the Panax notoginseng","volume":"64","author":"Xu","year":"2019","journal-title":"Folia Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7164\/antibiotics.50.900","article-title":"Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. I. Taxonomy, fermentation, isolation and antimicrobial activities","volume":"50","author":"Matsumoto","year":"1997","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"912","DOI":"10.7164\/antibiotics.50.912","article-title":"Epoxyquinomicins A, B, C and D, new antibiotics from Amycolatopsis. III. Physico-chemical properties and structure determination","volume":"50","author":"Matsumoto","year":"1997","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7164\/antibiotics.48.217","article-title":"Azicemicins A and B, a new antimicrobial agent produced by Amycolatopsis. I. Taxonomy, fermentation, isolation, characterization and biological activities","volume":"48","author":"Tsuchida","year":"1995","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_115","first-page":"148","article-title":"Azicemicins A and B, new antimicrobial agents produced by Amycolatopsis. II. Structure determination","volume":"48","author":"Tsuchida","year":"1995","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.13.4.598","article-title":"Cetocycline, tetracycline analog: In vitro studies of antimicrobial activity, serum binding, lipid solubility, and uptake by bacteria","volume":"13","author":"Proctor","year":"1978","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12934-020-01495-x","article-title":"Heterologous expression of the atypical tetracycline chelocardin reveals the full set of genes required for its biosynthesis","volume":"19","author":"Pikl","year":"2020","journal-title":"Microb. Cell Fact."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschembio.8b01125","article-title":"Engineering atypical tetracycline formation in Amycolatopsis sulphurea for the production of modified chelocardin antibiotics","volume":"14","author":"Fayad","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4014\/mbl.1705.05001","article-title":"Anti-proliferative and antioxidant activities of 1-methoxy-3-methyl-8-hydroxy-anthraquinone, a hydroxyanthraquinoid extrolite produced by Amycolatopsis thermoflava strain SFMA-103","volume":"45","author":"Kumar","year":"2017","journal-title":"Microbiol. Biotechnol. Lett."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7164\/antibiotics.25.11","article-title":"Tolypomycin, a new antibiotic. 3. Isolation and characterization of tolypomycin Y","volume":"25","author":"Kishi","year":"1972","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_121","unstructured":"Lapchinskaia, O.A., Katrukha, G.S., Terekhova, L.P., Pogozheva, V.V., Filicheva, V.A., Kharitonova, L.A., Lapchinskaia, M.Y., Yakovenko, A.N., Ponomarenko, V.I., and Orlova, G.I. (2019). The Amycolatopsis umgeniensis strain is a producer of the antibiotic eremomycin. (2689699 C1), Patent RU, (In Russian)."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0040-4039(01)02171-2","article-title":"Isolation and structure elucidation of vancoresmycin\u2014A new antibiotic from Amycolatopsis sp. ST 101170","volume":"43","author":"Hopmann","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acschembio.7b00733","article-title":"Mode of action and heterologous expression of the natural product antibiotic vancoresmycin","volume":"13","author":"Kepplinger","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/antibiotics3040572","article-title":"Old and new glycopeptide antibiotics: Action and resistance","volume":"3","author":"Binda","year":"2014","journal-title":"Antibiotics"},{"key":"ref_125","first-page":"606","article-title":"Vancomycin, a new antibiotic. \u0406. Chemical and biological properties","volume":"3","author":"McCormick","year":"1956","journal-title":"Antibiot. Annu."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited\u201460 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front. Public Health"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: A history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"5635","DOI":"10.1007\/s00253-018-8983-8","article-title":"Enhancement of A82846B yield and proportion by overexpressing the halogenase gene in Amycolatopsis orientalis SIPI18099","volume":"102","author":"Wang","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2000.tb09032.x","article-title":"Enterococcal-type glycopeptide resistance genes in non-enterococcal organisms","volume":"185","author":"Patel","year":"2000","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/cc1871","article-title":"Red man syndrome","volume":"7","author":"Sivagnanam","year":"2003","journal-title":"Crit. Care."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1021\/acs.accounts.0c00569","article-title":"Maxamycins: Durable antibiotics derived by rational redesign of vancomycin","volume":"53","author":"Wu","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Xu, L., Huang, H., Wei, W., Zhong, Y., Tang, B., Yuan, H., Zhu, L., Huang, W., Ge, M., and Yang, S. (2014). Complete genome sequence and comparative genomic analyses of the vancomycin-producing Amycolatopsis orientalis. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-363"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ja.2013.117","article-title":"Glycopeptide antibiotic biosynthesis","volume":"67","author":"Yim","year":"2014","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/anie.200390202","article-title":"Vancomycin assembly: Nature\u2019s way","volume":"42","author":"Hubbard","year":"2003","journal-title":"Angew. Chem. Int. Ed Engl."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.7164\/antibiotics.46.1181","article-title":"Structure-activity relationships of vancomycin-type glycopeptide antibiotics","volume":"46","author":"Nagarajan","year":"1993","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_136","unstructured":"Gause, G.F., Preobrazhenskaya, T.P., Laiko, A.V., Selezneva, T.I., Sveshnikova, M.A., Brazhnikova, M.G., Fedorova, G.B., Borisova, V.N., Tolstykh, I.V., and Proshlyakova, V.V. (1997). The antibiotic \u201ceremomycin\u201d and the method of its preparation. (SU 1475150 A1), Patent, (In Russian)."},{"key":"ref_137","first-page":"348","article-title":"Eremomycin\u2014A new antibiotic of the polycyclic glycopeptide group","volume":"34","author":"Gauze","year":"1989","journal-title":"Antibiot. Khimioter."},{"key":"ref_138","first-page":"523","article-title":"Glycopeptide antibiotics: Eremomycin, vancomycin, and teicoplanin. Comparison of several parameters of pharmacokinetics and antimicrobial activity","volume":"34","author":"Malkova","year":"1989","journal-title":"Antibiot. Khimioter."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1574-6968.12324","article-title":"Novel Amycolatopsis balhimycina biochemical abilities unveiled by proteomics","volume":"351","author":"Alduina","year":"2014","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.febslet.2012.04.025","article-title":"Synthetic Biology of secondary metabolite biosynthesis in actinomycetes: Engineering precursor supply as a way to optimize antibiotic production","volume":"586","author":"Wohlleben","year":"2012","journal-title":"FEBS Lett."},{"key":"ref_141","first-page":"84","article-title":"Ristocetin","volume":"Volume 1","author":"Gottlieb","year":"1967","journal-title":"Antibiotics. Mechanism of Action"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/rth2.12064","article-title":"Current issues in diagnosis and treatment of von Willebrand disease","volume":"2","author":"Keesler","year":"2017","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/ja00525a036","article-title":"Structure of avoparcin components","volume":"102","author":"McGahren","year":"1980","journal-title":"J. Am. Chem. Soc."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/jac\/44.5.593","article-title":"Interactions of \u03b1- and \u03b2-avoparcin with bacterial cell-wall receptor-mimicking peptides studied by electrospray ionization mass spectrometry","volume":"44","author":"Heck","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/eva.12185","article-title":"Antibiotics in agriculture and the risk to human health: How worried should we be?","volume":"8","author":"Chang","year":"2015","journal-title":"Evol. Appl."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e01780-18","DOI":"10.1128\/mBio.01780-18","article-title":"Genomic surveillance of Enterococcus faecium reveals limited sharing of strains and resistance genes between livestock and humans in the United Kingdom","volume":"9","author":"Gouliouris","year":"2018","journal-title":"mBio"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vetmic.2019.04.007","article-title":"Continuing occurrence of vancomycin resistance determinants in Danish pig farms 20 years after removing exposure to avoparcin","volume":"232","author":"Clasen","year":"2019","journal-title":"Vet. Microbiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","article-title":"Molecular mechanisms of vancomycin resistance","volume":"29","author":"Stogios","year":"2020","journal-title":"Protein Sci."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1021\/cr030103a","article-title":"Glycopeptide and lipoglycopeptide antibiotics","volume":"105","author":"Kahne","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14728222.7.3.311","article-title":"Vancomycin resistance: Occurrence, mechanisms and strategies to combat it","volume":"7","author":"Boneca","year":"2003","journal-title":"Expert. Opin. Ther. Targets."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM198807213190307","article-title":"Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium","volume":"319","author":"Leclercq","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/IDR.S54125","article-title":"Vancomycin-resistant enterococcal infections: Epidemiology, clinical manifestations, and optimal management","volume":"8","author":"Crank","year":"2015","journal-title":"Infect. Drug. Resist."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e03284-19","DOI":"10.1128\/mBio.03284-19","article-title":"Plasmids shaped the recent emergence of the major nosocomial pathogen Enterococcus faecium","volume":"11","author":"Top","year":"2020","journal-title":"mBio"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1038\/s41598-020-69058-z","article-title":"Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: A systematic review and meta-analysis","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1017\/S0195941700082333","article-title":"First case of VRSA identified in Michigan","volume":"23","author":"Bartley","year":"2002","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijmm.2014.12.015","article-title":"Self-resistance mechanisms of actinomycetes producing lipid II-targeting antibiotics","volume":"305","author":"Stegmann","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1128\/AAC.42.9.2215","article-title":"Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms","volume":"42","author":"Marshall","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1128\/AAC.01372-10","article-title":"Self-resistance and cell wall composition in the glycopeptide producer Amycolatopsis balhimycina","volume":"55","author":"Vollmer","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BFb0048448","article-title":"Ansamycins. Chemistry, biosynthesis and biological activity","volume":"72","author":"Wehrli","year":"1977","journal-title":"Top. Curr. Chem."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0025-7125(16)31449-3","article-title":"Rifampin","volume":"66","author":"Farr","year":"1982","journal-title":"Med. Clin. North Am."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10408419509113532","article-title":"Rifamycins: Strain improvement program","volume":"21","author":"Lal","year":"1995","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymben.2014.08.001","article-title":"Comparative genomics revealed key molecular targets to rapidly convert a reference rifamycin-producing bacterial strain into an overproducer by genetic engineering","volume":"26","author":"Peano","year":"2014","journal-title":"Metab. Eng."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.jim.7000069","article-title":"Antibiotic biosynthesis: From natural to unnatural compounds","volume":"27","author":"Floss","year":"2001","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-018-04772-x","article-title":"Deciphering the late steps of rifamycin biosynthesis","volume":"9","author":"Qi","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Robertsen, H.L., and Musiol-Kroll, E.M. (2019). Actinomycete-derived polyketides as a source of antibiotics and lead structures for the development of new antimicrobial drugs. Antibiotics, 8.","DOI":"10.3390\/antibiotics8040157"},{"key":"ref_166","first-page":"951","article-title":"Rifamycin SV. A review","volume":"15","author":"Bergamini","year":"1965","journal-title":"Arzneimittelforschung"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tube.2010.02.001","article-title":"Rifamycins-obstacles and opportunities","volume":"90","author":"Aristoff","year":"2010","journal-title":"Tuberculosis"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"S402","DOI":"10.1093\/clinids\/5.Supplement_3.S402","article-title":"History of the development of rifampin","volume":"5","author":"Sensi","year":"1983","journal-title":"Rev. Infect. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1099\/mic.0.28138-0","article-title":"Identification of tailoring genes involved in the modification of the polyketide backbone of rifamycin B by Amycolatopsis mediterranei S699","volume":"151","author":"Xu","year":"2005","journal-title":"Microbiology (Reading)"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.7164\/antibiotics.31.1124","article-title":"Early intermediates in the biosynthesis of ansamycins. I. Isolation and identification of protorifamycin I","volume":"31","author":"Ghisalba","year":"1978","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.7164\/antibiotics.32.1267","article-title":"Early intermediates in the biosynthesis of ansamycins. II. Isolation and identification of proansamycin B-M1 and protorifamycin i-M1","volume":"32","author":"Ghisalba","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"847","DOI":"10.7164\/antibiotics.33.847","article-title":"Early intermediates in the biosynthesis of ansamycins. III. Isolation and identification of further 8-deoxyansamycins of the rifamycin-type","volume":"33","author":"Ghisalba","year":"1980","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/S0040-4020(01)97557-X","article-title":"Structure of rifamycin W, a novel ansamycin from a mutant of Nocardia mediterranea","volume":"30","author":"Martinelli","year":"1974","journal-title":"Tetrahedron"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.7164\/antibiotics.34.1257","article-title":"Rifamycin Z, a novel ansamycin from a mutant of Nocardia mediterranea","volume":"34","author":"Cricchio","year":"1981","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF02178838","article-title":"Rifomycin IX. Two new antibiotics of rifomycin family: Rifomycin S and rifomycin SV. Preliminary report","volume":"16","author":"Sensi","year":"1960","journal-title":"Experientia"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"637","DOI":"10.7164\/antibiotics.22.637","article-title":"Isolation of rifamycin SV from a mutant Streptomyces mediterranei strain","volume":"22","author":"Lancini","year":"1969","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"949","DOI":"10.7164\/antibiotics.31.949","article-title":"Rifamycin R, a novel metabolite from a mutant of Nocardia mediterranea","volume":"31","author":"Martinelli","year":"1978","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7164\/antibiotics.29.466","article-title":"Rifamycin G, a further product of Nocardia mediterranei metabolism","volume":"29","author":"Lancini","year":"1976","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF02137934","article-title":"Rifomycin Y and its transformation products","volume":"23","author":"Leitich","year":"1967","journal-title":"Experientia"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/BF02136207","article-title":"Biogenesis of rifamycins. The conversion of rifamycin B into rifamycin Y","volume":"23","author":"Lancini","year":"1967","journal-title":"Experientia"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7164\/antibiotics.55.396","article-title":"New insights into rifamycin B biosynthesis: Isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways","volume":"55","author":"Stratmann","year":"2002","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_182","first-page":"228","article-title":"Rifomycin. V. Rifomycin O, a new antibiotic of the rifomycin family","volume":"15","author":"Sensi","year":"1960","journal-title":"Farmaco Sci."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Hanh, B.T.B., Park, J.W., Kim, T.H., Kim, J.S., Yang, C.S., Jang, K., Cui, J., Oh, D.C., and Jang, J. (2020). Rifamycin O, an alternative anti-Mycobacterium abscessus agent. Molecules, 25.","DOI":"10.3390\/molecules25071597"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"842","DOI":"10.7164\/antibiotics.33.842","article-title":"Thiazorifamycins. III. Biosynthesis of rifamycins P, Q and verde, novel metabolites from a mutant of Nocardia mediterranea","volume":"33","author":"Cricchio","year":"1980","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7164\/antibiotics.22.369","article-title":"Isolation and structure of rifamycin L and its biogenetic relationship with other rifamycins","volume":"22","author":"Lancini","year":"1969","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_186","unstructured":"Hengeller, C., Lancini, G., and Sensi, P. (1973). 27-Demethoxy-27-Hydroxyrifamycin Derivatives. (3743635A), US Patent."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"971","DOI":"10.7164\/antibiotics.34.971","article-title":"3-Hydroxyrifamycin S and further novel ansamycins from a recombinant strain R-21 of Nocardia mediterranei","volume":"34","author":"Traxler","year":"1981","journal-title":"J. Antibiot. (Tokyo)"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1517\/13543776.17.6.617","article-title":"New anti-tuberculosis therapies","volume":"17","author":"Portero","year":"2007","journal-title":"Expert Opin. Ther. Patents"},{"key":"ref_189","first-page":"753","article-title":"Development of antituberculous drugs: Current status and future prospects","volume":"81","author":"Tomioka","year":"2006","journal-title":"Kekkaku"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"a021147","DOI":"10.1101\/cshperspect.a021147","article-title":"Tuberculosis drug development: History and evolution of the mechanism-based paradigm","volume":"5","author":"Chakraborty","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/thoraxjnl-2012-201663","article-title":"MDR, XDR, TDR tuberculosis: Ominous progression","volume":"67","author":"Udwadia","year":"2012","journal-title":"Thorax"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fmicb.2020.00971","article-title":"Characterization of the rifamycin-degrading monooxygenase from rifamycin producers implicating its involvement in saliniketal biosynthesis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"a027011","DOI":"10.1101\/cshperspect.a027011","article-title":"Rifamycins, alone and in combination","volume":"6","author":"Rothstein","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"21142","DOI":"10.1074\/jbc.M114.572636","article-title":"Modification of rifamycin polyketide backbone leads to improved drug activity against rifampicin-resistant Mycobacterium tuberculosis","volume":"289","author":"Nigam","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_195","doi-asserted-by":"crossref","unstructured":"Shi, Y., Ye, F., Song, Y., Zhang, X., Lu, C., and Shen, Y. (2021). Rifamycin W analogues from Amycolatopsis mediterranei S699 \u0394rif-orf5 strain. Biomolecules, 11.","DOI":"10.3390\/biom11070920"},{"key":"ref_196","doi-asserted-by":"crossref","unstructured":"Ye, F., Shi, Y., Zhao, S., Li, Z., Wang, H., Lu, C., and Shen, Y. (2020). 8-Deoxy-rifamycin derivatives from Amycolatopsis mediterranei S699 \u0394rifT strain. Biomolecules, 10.","DOI":"10.3390\/biom10091265"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1021\/acsinfecdis.0c00223","article-title":"A Semisynthetic Kanglemycin shows in vivo efficacy against high-burden rifampicin resistant pathogens","volume":"6","author":"Peek","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.38.4.637","article-title":"Tetracycline analogs whose primary target is not the bacterial ribosome","volume":"38","author":"Chopra","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bbapap.2016.03.004","article-title":"Dual mechanism of action of the atypical tetracycline chelocardin","volume":"1864","author":"Stepanek","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1002\/anie.201411028","article-title":"Construction of a new class of tetracycline lead structures with potent antibacterial activity through biosynthetic engineering","volume":"54","author":"Horvat","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"112005","DOI":"10.1016\/j.ejmech.2019.112005","article-title":"Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics","volume":"188","author":"Grandclaudon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.gdata.2013.10.006","article-title":"Genome sequencing and annotation of Amycolatopsis vancoresmycina strain DSM 44592T","volume":"2","author":"Kaur","year":"2014","journal-title":"Genom. Data"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/s41579-020-0379-y","article-title":"Ecology and genomics of Actinobacteria: New concepts for natural product discovery","volume":"18","author":"Terlouw","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1021\/acs.orglett.7b03113","article-title":"Amycolamycins A and B, two enediyne-derived compounds from a locust-associated Actinomycete","volume":"19","author":"Ma","year":"2017","journal-title":"Org. Lett."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/10\/1254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:15:39Z","timestamp":1760166939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/10\/10\/1254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":204,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["antibiotics10101254"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics10101254","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}